SCHEMBL9350504

SCHEMBL9350504

CCCC(=O)c1cnc2c(OCCCN(C)C)cccc2c1Nc1ccc(F)cc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9268825 0.90 — —
SCHEMBL9349250 0.90 ATP4A (0.75) —
SCHEMBL9273781 0.89 — —
SCHEMBL8188049 0.87 — —
SCHEMBL8179991 0.87 — —
SCHEMBL9158359 0.87 — —
SCHEMBL9266013 0.86 — —
SCHEMBL8187650 0.86 — —
SCHEMBL9350500 0.85 ATP4A (0.76) —
SCHEMBL9160371 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0416749-B1 Substituted 4-aminoquinolines SMITHKLINE BEECHAM INTERCREDIT (NL) 1994-08-17 — — EP claimed
US-5082841-A Enzyme inhibitor SMITHKLINE BEECHAM INTERCREDIT B.V. (GB) 1992-01-21 — — US claimed
EP-0416749-B1 Substituted 4-aminoquinolines SMITHKLINE BEECHAM INTERCREDIT (NL) 1994-08-17 — — EP disclosed
US-5082841-A Enzyme inhibitor SMITHKLINE BEECHAM INTERCREDIT B.V. (GB) 1992-01-21 — — US disclosed
EP-0416749-A2 Substituted 4-aminoquinolines SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1991-03-13 — — EP disclosed
Send feedback